Evaluation of CD3 and CD8 T-Cell Immunohistochemistry for Prognostication and Prediction of Benefit From Adjuvant Chemotherapy in Early-Stage Colorectal Cancer Within the QUASAR Trial.

Williams, C.J.M. orcid.org/0000-0002-1574-653X, Gray, R., Hills, R.K. et al. (22 more authors) (2024) Evaluation of CD3 and CD8 T-Cell Immunohistochemistry for Prognostication and Prediction of Benefit From Adjuvant Chemotherapy in Early-Stage Colorectal Cancer Within the QUASAR Trial. Journal of Clinical Oncology, 42 (29). pp. 3430-3442. ISSN 0732-183X

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2024 by American Society of Clinical Oncology. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial No Derivatives 4.0 License.

Keywords: Biomedical and Clinical Sciences; Oncology and Carcinogenesis; Immunology; Digestive Diseases; Prevention; Women's Health; Cancer; Colo-Rectal Cancer; Cancer
Dates:
  • Published: October 2024
  • Published (online): 31 July 2024
  • Accepted: 7 May 2024
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Pathology and Data Analytics
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Oncology
Depositing User: Symplectic Publications
Date Deposited: 13 Aug 2024 14:13
Last Modified: 04 Dec 2024 16:07
Status: Published
Publisher: American Society of Clinical Oncology
Identification Number: 10.1200/jco.23.02030
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics